APPLICATIONS PUBLISHED 30 MARCH 2005
Fungicidal mixtures based on bazamidoxine derivatives, benzophenones and on an azole
BASF 1517608*
Fungicidal combinations of active substances
Bayer CropSciences 1517609*
Fungicidal combination of active substances
Bayer CropScience 1517610*
A unit for checking the dosing of pharmaceutical material in a capsule filling machine
I. M. A. Industria Macchine Automatiche 1517614*
Administration form of the oral administration of active substances, vitamins and/or nutrients
Gruenenthal 1517615*
Compsns and methods for reduction of inflammatory symptoms and/or biomarkers in female subjects
Galileo Pharmaceuticals 1517667*
Dosage forms for increasing the solubility and extending the release of drugs such as eg topiramate and phenyton
Alza Corp 1517671*
Compsns and methods for amelioration of human female sexual dysfunction
Nexmed (Holdings) 1517672*
Nasal compsn comprising a mucopolysaccharide and propylene glycol
Novartis Consumer Health 1517673*
Preparation for the intranasal application of selected CGRP antagonists derived from amino acids and a method for their production
Boehringer Ingelheim Pharma 1517674*
Compsn for treatment of inflammatory disorders
Universiteit Utrecht Holding 1517675*
Oral dosage forms comprising fenofibrate
Skyepharma Canada 1517676*
Popping oral administration form
CTS Chemical Industries 1517677*
Process for the preparation of robust formulations of valacyclovir hydrochloride tablets
Ranbaxy Laboratories 1517678*
Ortho-substituted benzoic acid derivatives for the treatment of insulin resistance
AstraZeneca 1517679*
Benzoic acid derivatives as modulators of PPAR alpha and gamma
AstraZeneca 1517680*
Peritoneal dialysate containing taurine
JMS 1517681*
Pharmaceutical formulation comprising non-peptide renin inhibitor and surfactant
Speedel Pharma 1517682*
Sustained release tablet containing indapamide
PLIVA Krakow 1517683*
Fluorinated chlorin and bacteriochlorin photosensitisers for photodynamic therapy
Health Research 1517684*
2-(phenyl)-2H-pyrazole-3-carboxylic acid-N-4-(thioxo-heterocyclyl)-phenyl-amide derivatives and corresponding amino-heterocyclyl derivatives and related compounds for use as inhibitors of the coagulation factors XA and/or VIIA for treating thromboses
Merck Patent 1517685*
Use of dantrolene, a ryanodine antagonist, in treating neural injury
Allergan 1517686*
Medicament for the treatment of the systemic inflammatory response syndrome
Boehringer Ingelheim Pharma 1517687*
Medicament for the treatment of diseases requiring inhibition or a reduction in the activity of pH value-regulating bicarbonate transporter proteins
Solvay Pharmaceuticals 1517688*
Selective analgesic agents
Regents of the University of Minnesota 1517689*
Liquid dosage forms of non-enterically coated acid-labile drugs
Abbott Laboratories 1517690*
Use of dopamine receptor agonists for the treatment of cutaneous tumours, warts and scars
Wank, Rudolf 1517691*
Method and agent for the prevention, inhibition and treatment of sepsis
B. R. A. H. M. S. Aktiengesellschaft 1517692*
Pharmaceutical compsns
Medipearl Pte 1517693*
Plant extracts
Ole Kaae Hansen Holding 1517694*
Osteopontin, oligodendrocytes and myelination
Aventis Pharmaceuticals 1517695*
Prevention, therapy and prognosis monitoring in sepsis and septic shock
Nederlandse Organisatie Voor Togepastnatuurwetenschappellijk Onderzoek TNO 1517696*
Acidic insulin preparations with improved stability
Aventis Pharma Deutschland 1517697*
Stabilised solid compsns of factor VII polypeptides
Novo Nordisk 1517698*
Pharmaceutical preparation and method of treatment of human malignancies with arginine deprivation
Bio-Cancer Treatment International 1517699*
Mucin fusion polypeptide vaccines, compsns and methods of use thereof
Recopharma 1517700*
Lewis Y epitope containing mucin fusion polypeptide vaccines, compsns and methods of use thereof
Recopharma 1517701*
Immunogenic HBC chimer particles stabilised with an N-terminal cysteine
Apovia 1517702*
Placental growth factor as a target for the treatment of osteoporosis
Vlaams Interuniversitair Instituut voor Biotechnologie 1517703*
Use of antibodies against FLT-1 for the treatment of osteoporosis
Vlaams Interuniversitair Instituut voor Biotechnologie 1517704*
Dichloroacetate in combination with cardioprotective or haemodynamic drugs
The Governors of the University of Alberta 1517705*
Combination of a proton pump inhibitor and a respiratory agent of the treatment of respiratory diseases
Altana Pharma 1517706*
Treatment for depression and anxiety with the combination of a PDE IV inhibitor and an antidepressant or an anxiolytic agent
Pfizer Products 1517707*
Combination treatment for depression and anxiety by NK1 and NK3 antagonists
Pfizer Products 1517708*
Transdermal drug delivery system
Sintov, Amnon 1517709*
Pegylated factor VII glycoforms
Novo Nordisk 1517710*
Method for disinfection inside an air lock and method for the implementation thereof
Bonnard, Eric 1517711*
Electrically heated vapour dispensing apparatus
Reckitt Benckiser 1517712*
4-(3,3-dihalo-O-allyloxy)phenoxy alkyl derivatives
Syngenta Pharmaceuticals 1517881*
Amide linker peroxisome proliferator activated receptor modulators
Eli Lilly 1517882*
Ortho-substituted benzoic acid derivatives for the treatment of insulin resistance
AstraZeneca 1517883*
A process for the preparation of 3-cyano-1-naphthoic acid and some analogues thereof
AstraZeneca 1517884*
Aminoacetonitrile derivatives suitable for controlling parasites
Novartis 1517885*
Novel phthalamide derivatives
Bayer CropScience 1517886*
N-sulphonylaminoacetonitriles having pesticidal properties
Novartis 1517887*
Method for synthesis of hydrogenofluoromethylenesulphonyl radical derivatives
Rhodia Chimie 1517888*
Nitrooxyderivatives of cyclooxygenase-2 inhibitors
Nicox 1517889*
Cationically substituted diphenyl azetidinones, method for their production, medicaments containing said compounds and use thereof
Aventis Pharma 1517890*
Diphenyl azetidinones substituted by acidic groups, method for their production, medicaments containing said compounds and use thereof
Aventis Pharma Deutschland 1517891*
Ring-substituted diphenyl azetidinones, method for the production thereof, medicaments containing said compounds, and use thereof
Aventis Pharma 1517892*
Process for producing levetiracetam
Teva Pharmaceutical Industries 1517893*
N-benzyl-3-phenyl-3-heterocyclyl-propionamide compounds as tachykinin antagonists and/or serotonin reuptake inhibitors
Glaxo Group 1517894*
8-(biaryl) quinoline PDE4 inhibitors
Merck Frosst Canada 1517895*
Phenyl- and pyridyl-diazaheterocycles having a TNF-modulating activity
Sanofi-Aventis 1517896*
Benzimidazole compounds and their use as estrogen agonists/antagonists
Pfizer Products 1517897*
Arylcarbonylpiperazines and heteroarylcarbonylpiperazines and the use thereof for treating benign and malignant tumour diseases
Zentaris 1517898*
Broad spectrum substituted benzisoxazole sulphonamide HIV protease inhibitors
Tibotac Pharmaceuticals 1517899*
Process for the production of N-(2,6-dimethyl-phenyl)-2-piperazin-1-yl-acetamide
Janssen Pharmaceutica 1517900*
Lactone compounds, for use as antioxidant agents in pharmaceutical, cosmetic or food compsns
Commisariat àl"Energie Atomique 1517902*
Marked malemide compounds, method for preparing same and use thereof for marking macromolecules
Commisariat àl"Energie Atomique 1517903*
Mitotic kinesin inhibitors
Merck 1517904*
Processes for preparing substituted pyrimidines and pyrimidine derivatives as inhibitors of protein kinases
Vertex Pharmaceuticals 1517905*
Method for the production of 1,2,4-triazolylmethyl-oxiranes
BASF 1517906*
Azabicyclo-octane and nonase derivatives with DDP-IV inhibiting activity
Sanofi-Aventis 1517907*
Novel benzimidazole derivatives
Banyu Pharmaceutical 1517908*
Novel tetracyclic arylcarbonyl indoles having serotonin receptor affinity useful as therapeutic agents, process for their preparation and pharmaceutical compsns containing them
Suven Life Sciences 1517909*
Phosphoramidites for coupling oligonucleotides to (2+2) photoreactive groups
Amersham Biosciences 1517910*
Tumour-inhibiting platinum (II) oxalate complexes
Faustus Forschungs Cie Translational Cancer Research 1517911*
Methods and compsns to treat pain and painful disorders using 577, 20739 or 57145
Millennium Pharmaceuticals 1517912*
A mycobacterium tuberculosis coding sequence for expression of heterologous proteins
Corixa Corp 1517913*
9-alpha-substituted estratrienes as selectively active oestrogen
Schering Aktiengesellschaft 1517914*
Prodrugs of excitatory amino acids
Eli Lilly 1517915*
Peptides having antimicrobial properties and compsns containing same in particular for preserving foods
Centre National de la Recherche Scientifique 1517916*
Human ERG2 potassium channel
Merck 1517917*
Peptides having affinity for phospholipid and uses
Commisariat àl"Energie Atomique 1517918*
Marked peptides having affinity for phospholipid and uses
Commisariat àl"Energie Atomique 1517919*
Product
Affitech 1517920*
Immunoglobulin single variable antigen-binding domains and dual specific constructs thereof
Dormantis 1517921*
Preparation based on an antibody directed against a tumour-associated glycosylation such as lewis structures
Igeneon Krebs-immunotherapie Forschungs- und Entwicklungs-AG 1517922*
Compnsn and methods for inhibiting microbial adhesion
Rcopharma AM 1517923*
Process for the manufacture of N-acyl-(epi)k5-amine-O-sulphate-derivatives and products thus obtained
Glycores 2000 1517924*
Process for making de-esterified pectins, their compsn and uses thereof
CP Kelco ApS 1517925*